Literature DB >> 30024462

Does THA Improve Social Status Among Turkish Women With Developmental Dysplasia of the Hip?

Tansel Mutlu1, Uygar Daşar, Ali Bicimoglu.   

Abstract

BACKGROUND: In traditional societies, patients who reach adulthood with developmental dysplasia of the hip (DDH) may be labeled "disabled" and may be considered "defective," causing them psychologic pain and problems with social interactions. In some patriarchal societies, women disproportionately experience these problems, because they may be seen as insufficient in terms of marriage and sexual intercourse owing to hip-related limitations, and they may be married through arranged marriages to people who also have disabilities. This patriarchal structure limits the ways women can engage in society and may lower their quality of life (QOL). The degree to which THA can improve the lives of women in these specific ways in a patriarchal culture has not, to our knowledge, been studied. QUESTIONS/PURPOSES: (1) Does THA improve the social standing of young women with DDH in Turkey? (2) Does THA improve QOL of young women with DDH in Turkey? (3) Does THA improve pain and physical function in these patients?
METHODS: This study was a retrospective, comparative study performed at Karabük University Research and Training Hospital in Karabük, Turkey, from 2012 to 2017. A total of 217 women with DDH were followed at our center between the study dates. All of these patients were evaluated for inclusion into the study. Among these, 175 women with DDH (aged 20-45 years) were included in the study according to inclusion/exclusion criteria. We offered THA to all patients in whom surgery was technically feasible; 84 chose to undergo THA, whereas 91 declined the procedure. Whether THA had any effects on the study questions was determined by comparison of the following findings at baseline and after intervention. The social standing of patients was assessed through their marital status and proportions of employment and depression; the patients' QOL was assessed with the SF-36 at baseline for all patients and at 1 year postoperatively for those who underwent THA; and pain and dysfunction were evaluated by determination of the proportion of patients who had scoliosis, knee valgus, and knee and lumbar pain. At baseline, patients were not different in regard to all parameters except knee and lumbar pain, which were greater in those who had decided to undergo THA. The SF-36 scores of patients who underwent THA were compared with their postoperative scores as well as with the baseline scores of patients who did not undergo THA.
RESULTS: In terms of measures of social standing, women who underwent THA appeared better at followup than did the patients who did not undergo THA. Those who underwent THA had higher percentages of marriage and employment and less depression. Regarding QOL, postintervention comparisons revealed that women who underwent THA had higher SF-36 scores compared with the initial results of women who did not have surgery. Compared with preoperative scores, the highest improvements were found in social role function (mean difference ± standard error [SE] = 58.64 ± 0.88; 95% confidence interval [CI], 56.91-60.37; p < 0.001) and mental health (mean difference ± SE = 53.00 ± 0.86; 95% CI, 51.31-54.69; p < 0.001) subdimensions of the SF-36. Finally, patients who underwent THA had improvements in pain and function as measured by Harris hip score than did patients who did not undergo THA. At initial evaluation, two groups were found to be similar in terms of Harris hip scores (THA: 61.6 ± 7.4 versus non-THA: 63.7 ± 7.6, p = 0.066), whereas the THA group was found to be superior at followup evaluation (THA: 83.5 ± 6.2 versus non-THA: 62.1 ± 7.8, p = 0.001).
CONCLUSIONS: Young women with DDH are severely affected by social and cultural norms in Turkey, which is an example of a patriarchal culture. We believe that in this setting, some patients who improve their appearance, gait, and physical function through THA may benefit from a better social perception and higher self-esteem, which may, in turn, increase their QOL and provide more freedom in terms of life choices. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2018        PMID: 30024462      PMCID: PMC6259788          DOI: 10.1097/CORR.0000000000000403

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  12 in total

1.  Periacetabular osteotomy and total hip arthroplasty in patients older than 40 years.

Authors:  Donald S Garbuz; Mohammad A Awwad; Clive P Duncan
Journal:  J Arthroplasty       Date:  2008-03-14       Impact factor: 4.757

2.  [Effectiveness of total hip arthroplasty for severe developmental dysplasia of hip in adults].

Authors:  Jianxin Zhu; Yue Wang; Jian Pang; Bo Lü; Chongxin Huang; Peng Hao; Bo Tan
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2014-03

3.  An evaluation of patients' quality of life before, 6 weeks and 6 months after total hip replacement surgery.

Authors:  S Knutsson; I B Engberg
Journal:  J Adv Nurs       Date:  1999-12       Impact factor: 3.187

Review 4.  Total hip Replacement in Crowe type IV dysplastic hips - average 5 year follow-up and literature review.

Authors:  J K Jain; S Agarwal; R K Sharma
Journal:  Acta Orthop Belg       Date:  2016-09       Impact factor: 0.500

Review 5.  Cochrane Review: Screening programmes for developmental dysplasia of the hip in newborn infants.

Authors:  Damon Shorter; Timothy Hong; David A Osborn
Journal:  Evid Based Child Health       Date:  2013-01

6.  Depression and anxiety before and after limb length discrepancy correction in patients with unilateral developmental dysplasia of the hip.

Authors:  Ruiyu Liu; Yongwei Li; Lihong Fan; Mingchao Mu; Kunzheng Wang; Wei Song
Journal:  J Psychosom Res       Date:  2015-08-08       Impact factor: 3.006

7.  Total hip arthroplasty in young females with congenital dislocation of the hip, radically improves their long-term quality of life.

Authors:  Nikolaos T Roidis; Athanasios P Pollalis; George C Hartofilakidis
Journal:  J Arthroplasty       Date:  2013-04-06       Impact factor: 4.757

Review 8.  Lessons learned from study of congenital hip disease in adults.

Authors:  George Hartofilakidis; Kalliopi Lampropoulou-Adamidou
Journal:  World J Orthop       Date:  2016-12-18

9.  Quality of life evaluation in patients affected by osteoarthritis secondary to congenital hip dysplasia after total hip replacement.

Authors:  Alessandra Tellini; Vincenza Ciccone; Davide Blonna; Roberto Rossi; Antongiulio Marmotti; Filippo Castoldi
Journal:  J Orthop Traumatol       Date:  2008-08-16

10.  Epidemiology, demographics, and natural history of congenital hip disease in adults.

Authors:  G Hartofilakidis; T Karachalios; K G Stamos
Journal:  Orthopedics       Date:  2000-08       Impact factor: 1.390

View more
  4 in total

1.  Editor's Spotlight/Take 5: Does THA Improve Social Status Among Turkish Women with Developmental Dysplasia of the Hip?

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

2.  Editor's Spotlight/Take 5: What is the Interobserver Reliability of an Ultrasound-enhanced Physical Examination of the Hip in Infants? A Prospective Study on the Ease of Acquiring Skills to Diagnose Hip Dysplasia.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2021-09-01       Impact factor: 4.755

3.  Rapid and Severe Idiopathic Aseptic Necrosis of the Contralateral Femoral Head after Unilateral Total Hip Arthroplasty.

Authors:  Qihang Su; Yi Zhang; Yuanzhen Zhang; Bin'an Zhao; Heng'an Ge; Peng Wu; Jun Li; Biao Cheng
Journal:  Orthop Surg       Date:  2022-05-07       Impact factor: 2.279

4.  Sex Differences in the Mediating Effect of Kinesiophobia on Chronic Pain, Dysesthesia, and Health-Related Quality of Life in Japanese Individuals Aged 65 Years Old and Older Treated with Surgery for Lumbar Spinal Stenosis.

Authors:  Daisuke Higuchi; Yu Kondo; Yuta Watanabe; Takahiro Miki
Journal:  J Pain Res       Date:  2022-06-30       Impact factor: 2.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.